东亚药业股价涨5.75%，诺安基金旗下1只基金位居十大流通股东，持有81.17万股浮盈赚取86.86万元

Group 1 - East Asia Pharmaceutical's stock price increased by 5.75% on January 8, reaching 19.69 CNY per share, with a trading volume of 28.52 million CNY and a turnover rate of 1.33%, resulting in a total market capitalization of 2.259 billion CNY [1] - The stock has risen for three consecutive days, with a cumulative increase of 4.61% during this period [1] - The company, established on February 6, 1998, and listed on November 25, 2020, specializes in the research, production, and sales of chemical raw materials and pharmaceutical intermediates [1] Group 2 - The main revenue composition of East Asia Pharmaceutical includes: β-lactam antibiotics (44.84%), anticholinergic and synthetic antispasmodic drugs (23.92%), quinolone antibiotics (12.86%), antifungal drugs for skin use (8.87%), and other products (5.05%) [1] - Notably, the fund "Nuoan Multi-Strategy Mixed A" (320016) has entered the top ten circulating shareholders of East Asia Pharmaceutical, holding 811,700 shares, which is 0.72% of the circulating shares [2] - The fund has generated a floating profit of approximately 868,600 CNY today, with a floating profit of 665,600 CNY during the three-day increase [2]